About tRNA (adenine(37)-N6)-methyltransferase
tRNA (adenine(37)-N6)-methyltransferase (TRMO) is a protein
from Homo sapiens identified by UniProt accession
Q9BU70, 441 residues long.
MolForge cross-references it against 0 known binders and
40 disease associations.
Target properties
| Protein name | tRNA (adenine(37)-N6)-methyltransferase |
| UniProt accession | Q9BU70 |
| Gene | TRMO |
| Organism | Homo sapiens |
| Length | 441 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (40)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.37
- platelet count · score 0.36
- thyroid carcinoma · score 0.32
- blood protein measurement · score 0.29
- HbA1c measurement · score 0.27
- thyroid stimulating hormone measurement · score 0.24
- platelet component distribution width · score 0.24
- platelet crit · score 0.23
- thyroid cancer · score 0.22
- Red cell distribution width · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BU70-F1 | alphafold | PREDICTED | 67.47 | — |
Amino-acid sequence (441 residues)
MRGLEESGPR PTATPCGCVK PALETGNLLT EPVGYLESCF SAKNGTPRQP SICSYSRACL RIRKRIFNNP EHSLMGLEQF SHVWILFVFH KNGHLSCKAK VQPPRLNGAK TGVFSTRSPH RPNAIGLTLA KLEKVEGGAI YLSGIDMIHG TPVLDIKPYI AEYDSPQNVM EPLADFNLQN NQHTPNTVSQ SDSKTDSCDQ RQLSGCDEPQ PHHSTKRKPK CPEDRTSEEN YLTHSDTARI QQAFPMHREI AVDFGLESRR DQSSSVAEEQ IGPYCPEKSF SEKGTDKKLE RVEGAAVLQG SRAETQPMAP HCPAGRADGA PRSVVPAWVT EAPVATLEVR FTPHAEMDLG QLSSQDVGQA SFKYFQSAEE AKRAIEAVLS ADPRSVYRRK LCQDRLFYFT VDIAHVTCWF GDGFAEVLRI KPASEPVHMT GPVGSLVSLG S
Explore tRNA (adenine(37)-N6)-methyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets